1. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
- Author
-
NianMin Shi, Yun-hua Bai, Li Li, Zheng Zhang, Xing Ai, Jing Wang, Feng-ji Luo, Zijian Feng, and JianXin Ma
- Subjects
Male ,China ,Pediatrics ,medicine.medical_specialty ,Drug-Related Side Effects and Adverse Reactions ,Rabies ,030231 tropical medicine ,Immunology ,Antibodies, Viral ,03 medical and health sciences ,0302 clinical medicine ,Rabies vaccine ,Chlorocebus aethiops ,medicine ,Animals ,Humans ,Technology, Pharmaceutical ,Immunology and Allergy ,030212 general & internal medicine ,Vero Cells ,Immunization Schedule ,Aged ,Aged, 80 and over ,Pharmacology ,business.industry ,Immunogenicity ,Age Factors ,Chinese adults ,Middle Aged ,medicine.disease ,Serum samples ,Research Papers ,Antibodies, Neutralizing ,Vaccination ,Regimen ,Rabies Vaccines ,Vero cell ,Female ,business ,medicine.drug - Abstract
Background: Two kinds of regimens (2-1-1 and 1-1-1-1-1) can be selected after Zagreb regimen(2-1-1)of PVRV was officially approved in Beijing in January 2015. Up to now, the subjects for most studies about the comparison between Zagreb and Essen regimen are under 50 y old, rarely at and above. Aging of the immune system may result in decreasing efficacy of vaccination, especially for adults aged above 65–70 y. This study compared the safety and immunogenicity of the Zagreb and Essen regimen in Chinese adults aged 50 and above with the goal to provide a supplemental data for this age group. Methods: A total of 114 cases were divided into 2 groups randomly, received PVRV under the Zagreb and Essen regimens respectively. Serum samples were collected at D0, D7, D14, D42, D180 and D365 to determine the rabies serum neutralizing antibody by rapid fluorescent focus inhibition test (RFFIT). Safety analyses were made by comparing the AEs in day-3, day-7, and day-(7 + 21) in Zagreb or day-(7 + 28) in Essen by gender and age cohorts. Results: 617 blood samples were obtained. Two groups showed similar immunogenicity, the neutralizing antibody titer of all subjects at D14 and D42 showed >0.5 IU/ml. Under the same regimen, Subjects ≥65 y had lower GMC than those who
- Published
- 2017